Activity

Filter

Cancel
Date Panel Item Activity
8 actions
Skeletal dysplasia v2.181 HS2ST1 Eleanor Williams Phenotypes for gene: HS2ST1 were changed from Intellectual disability; dysmorphic features; congenital anomalies to Intellectual disability; dysmorphic features; congenital anomalies; Neurofacioskeletal syndrome with or without renal agenesis,OMIM:619194
Skeletal dysplasia v2.180 HS2ST1 Eleanor Williams Tag for-review was removed from gene: HS2ST1.
Skeletal dysplasia v2.176 HS2ST1 Eleanor Williams commented on gene: HS2ST1
Skeletal dysplasia v2.175 HS2ST1 Eleanor Williams Source Expert Review Green was added to HS2ST1.
Rating Changed from Amber List (moderate evidence) to Green List (high evidence)
Skeletal dysplasia v2.80 HS2ST1 Michael Oldridge reviewed gene: HS2ST1: Rating: GREEN; Mode of pathogenicity: None; Publications: 33159882; Phenotypes: ID, facial dysmorphism, skeletal abnormalities; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal
Skeletal dysplasia v2.40 HS2ST1 Ivone Leong Classified gene: HS2ST1 as Amber List (moderate evidence)
Skeletal dysplasia v2.40 HS2ST1 Ivone Leong Gene: hs2st1 has been classified as Amber List (Moderate Evidence).
Skeletal dysplasia v2.39 HS2ST1 Ivone Leong gene: HS2ST1 was added
gene: HS2ST1 was added to Skeletal dysplasia. Sources: Literature
for-review tags were added to gene: HS2ST1.
Mode of inheritance for gene: HS2ST1 was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: HS2ST1 were set to 33159882
Phenotypes for gene: HS2ST1 were set to Intellectual disability; dysmorphic features; congenital anomalies
Review for gene: HS2ST1 was set to AMBER
Added comment: This gene is not associated with a relevant phenotype in OMIM or Gene2Phenotype. Only 2 of 3 unrelated families with affected individuals described in PMID: 33159882 were reported to have ID. The affected individuals in the third family could not be assessed for ID. Other features affected individuals had were muscular hypotonia, hypoplasia/agenesis of corpus callosum, skeletal abnormalities, uni/bilateral renal agenesis (2/3) and craniofacial dysmorphism. After consulting the Genomics England Clinical Team, it was decided that this gene should be added to this panel with an Amber rating. The skeletal phenotype is relatively mild and the GMS specialist group should review whether this gene is appropriate for this panel.
Sources: Literature